Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of NATH BIO GENES. For more details, see the NATH BIO GENES quarterly results and NATH BIO GENES share price.
1 Day | % | 0.3 |
No. of shares | m | 19.00 |
1 Week | % | 5.0 |
1 Month | % | 11.2 |
1 Year | % | 23.1 |
52 week H/L | Rs | 243.7/155.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
NATH BIO GENES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 585 | 484 | 416 | 475 | 262 | |
Low | Rs | 328 | 126 | 137 | 193 | 128 | |
Sales per share (Unadj.) | Rs | 121.5 | 147.3 | 161.9 | 146.5 | 158.6 | |
Earnings per share (Unadj.) | Rs | 20.2 | 26.6 | 29.3 | -35.5 | 18.4 | |
Diluted earnings per share | Rs | 20.2 | 26.6 | 29.3 | -35.5 | 18.4 | |
Cash flow per share (Unadj.) | Rs | 21.0 | 27.3 | 30.8 | -33.8 | 20.0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 2.00 | 2.00 | 2.00 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 2.00 | 2.00 | 2.00 | |
Avg Dividend yield | % | 0 | 0 | 0.7 | 0.6 | 1.0 | |
Book value per share (Unadj.) | Rs | 267.1 | 293.5 | 322.8 | 285.2 | 301.7 | |
Adj. book value per share | Rs | 267.1 | 293.4 | 322.7 | 285.2 | 301.6 | |
Shares outstanding (eoy) | m | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | |
Price / Sales ratio | x | 3.8 | 2.1 | 1.7 | 2.3 | 1.2 | |
Avg P/E ratio | x | 22.6 | 11.5 | 9.4 | -9.4 | 10.6 | |
P/CF ratio (eoy) | x | 21.7 | 11.2 | 9.0 | -9.9 | 9.7 | |
Price / Book Value ratio | x | 1.7 | 1.0 | 0.9 | 1.2 | 0.6 | |
Dividend payout | % | 0 | 0 | 6.8 | -5.6 | 10.9 | |
Avg Mkt Cap | Rs m | 8,672 | 5,798 | 5,253 | 6,341 | 3,707 | |
Total wages/salary | Rs m | 164 | 187 | 237 | 248 | 233 |
NATH BIO GENES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,309 | 2,799 | 3,076 | 2,784 | 3,014 | |
Other income | Rs m | 23 | 18 | 17 | 19 | 6 | |
Total revenues | Rs m | 2,332 | 2,817 | 3,092 | 2,802 | 3,019 | |
Gross profit | Rs m | 434 | 548 | 668 | -516 | 488 | |
Depreciation | Rs m | 14 | 15 | 28 | 31 | 30 | |
Interest | Rs m | 53 | 67 | 89 | 106 | 102 | |
Profit before tax | Rs m | 389 | 485 | 568 | -634 | 362 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 4 | -20 | 11 | 40 | 12 | |
Profit after tax | Rs m | 384 | 505 | 557 | -674 | 350 | |
Gross profit margin | % | 18.8 | 19.6 | 21.7 | -18.5 | 16.2 | |
Effective tax rate | % | 1.1 | -4.1 | 1.9 | -6.2 | 3.2 | |
Net profit margin | % | 16.6 | 18.0 | 18.1 | -24.2 | 11.6 |
NATH BIO GENES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 4,098 | 4,723 | 5,361 | 4,678 | 5,208 | |
Current liabilities | Rs m | 1,387 | 1,696 | 1,730 | 1,943 | 2,165 | |
Net working cap to sales | % | 117.4 | 108.2 | 118.1 | 98.2 | 101.0 | |
Current ratio | x | 3.0 | 2.8 | 3.1 | 2.4 | 2.4 | |
Inventory Days | Days | 10 | 14 | 8 | 35 | 33 | |
Debtors Days | Days | 170,741,371 | 139,533,671 | 1,298 | 1,122 | 1,179 | |
Net fixed assets | Rs m | 2,382 | 2,569 | 2,534 | 2,717 | 2,720 | |
Share capital | Rs m | 190 | 190 | 190 | 190 | 190 | |
"Free" reserves | Rs m | 4,886 | 5,386 | 5,943 | 5,229 | 5,542 | |
Net worth | Rs m | 5,076 | 5,576 | 6,133 | 5,419 | 5,732 | |
Long term debt | Rs m | 5 | 3 | 7 | 7 | 4 | |
Total assets | Rs m | 6,479 | 7,293 | 7,895 | 7,395 | 7,928 | |
Interest coverage | x | 8.3 | 8.3 | 7.4 | -5.0 | 4.5 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | |
Return on assets | % | 6.8 | 7.8 | 8.2 | -7.7 | 5.7 | |
Return on equity | % | 7.6 | 9.1 | 9.1 | -12.4 | 6.1 | |
Return on capital | % | 8.7 | 9.9 | 10.7 | -9.7 | 8.1 | |
Exports to sales | % | 1.2 | 2.2 | 0.5 | 0.7 | 2.7 | |
Imports to sales | % | 1.6 | 1.4 | 1.4 | 0 | 0.3 | |
Exports (fob) | Rs m | 29 | 60 | 14 | 19 | 81 | |
Imports (cif) | Rs m | 36 | 40 | 43 | 0 | 10 | |
Fx inflow | Rs m | 29 | 60 | 14 | 19 | 81 | |
Fx outflow | Rs m | 45 | 42 | 46 | 6 | 17 | |
Net fx | Rs m | -16 | 18 | -31 | 13 | 64 |
NATH BIO GENES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -229 | 95 | 11 | 170 | 384 | |
From Investments | Rs m | -205 | -144 | -103 | -199 | -29 | |
From Financial Activity | Rs m | 201 | 56 | 164 | -222 | -17 | |
Net Cashflow | Rs m | -233 | 6 | 72 | -250 | 338 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Satish Kagliwal | COMP SEC: Dhiraj Rathi | YEAR OF INC: 2000 | BSE CODE: 537291 | FV (Rs): 10 | DIV YIELD (%): 1.0 |
Read: NATH BIO GENES 2022-23 Annual Report Analysis
More Agriculture Company Fact Sheets: ADANI ENTERPRISES ADANI PORTS & SEZ ZOMATO APOLLO HOSPITALS ADANI TOTAL GAS
Compare NATH BIO GENES With: ADANI ENTERPRISES ADANI PORTS & SEZ ZOMATO APOLLO HOSPITALS ADANI TOTAL GAS
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.